Panbela Therapeutics News - PBLA

Company Name	Stock Ticker Symbol	Market	Type
Panbela Therapeutics Inc	PBLA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.11	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
			1.11	1.11

more quote information »

Recent News

Date	Time	Source	Heading
4/04/2024	16:17	EDGAR2	Form DEF 14A - Other definitive proxy statements
4/03/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
3/29/2024	17:24	EDGAR2	Form S-1 - General form for registration of securities under..
3/29/2024	17:08	EDGAR2	Form POS AM - Post-Effective amendments for registration..
3/26/2024	16:15	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/26/2024	16:12	EDGAR2	Form 8-K - Current report
3/26/2024	16:10	GLOBE	Panbela Provides Business Update and Reports Q4 and FY 2024..
3/26/2024	07:21	IHMARKETNEWS	U.S. Index Futures on the Rise, Oil Prices Show Stability
3/25/2024	16:15	EDGAR2	Form PRE 14A - Other preliminary proxy statements
3/12/2024	16:15	GLOBE	Panbela to Host Fourth Quarter and Year End 2023 Earnings..
3/07/2024	06:01	EDGAR2	Form 8-K - Current report
2/15/2024	08:05	EDGAR2	Form 8-K - Current report
2/15/2024	08:00	GLOBE	Panbela Regains Compliance with Nasdaq Listing Standards for..
2/13/2024	20:10	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	17:24	EDGAR2	Form 8-K - Current report
2/01/2024	07:15	EDGAR2	Form 8-K - Current report
2/01/2024	07:00	GLOBE	Panbela Announces Closing of Approximately $9.0 Million..
1/30/2024	17:28	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
1/30/2024	08:15	GLOBE	Acceptance of Ivospemin (SBP-101) Abstract for Poster..
1/29/2024	06:21	EDGAR2	Form 8-K - Current report
1/29/2024	06:15	GLOBE	Panbela Announces Pricing of Approximately $9.0 Million..
1/25/2024	12:22	EDGAR2	Form S-1/A - General form for registration of securities..
1/25/2024	08:54	EDGAR2	Form S-1/A - General form for registration of securities..
1/25/2024	07:00	GLOBE	Panbela Exceeds 50% Enrollment for Aspire Trial in..
1/22/2024	06:08	EDGAR2	Form S-1/A - General form for registration of securities..
1/19/2024	17:20	EDGAR2	Form 8-K - Current report
1/18/2024	08:15	GLOBE	Panbela Announces Publication of Clinical Data Titled: Phase..
1/16/2024	08:00	GLOBE	Panbela Announces 1-for-20 Reverse Stock Split Effective..
1/05/2024	16:34	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
12/21/2023	09:25	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/21/2023	09:25	EDGAR2	Form 8-K - Current report
12/21/2023	09:15	GLOBE	Panbela Therapeutics Announces Exercise of Warrants and..
12/21/2023	06:00	EDGAR2	Form 8-K - Current report
12/18/2023	08:15	GLOBE	Panbela Therapeutics Announces US WorldMeds NDA Approval for..
12/04/2023	08:00	GLOBE	Panbela Announces Publication of Abstract Titled: Evaluation..
12/01/2023	16:15	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/01/2023	16:15	EDGAR2	Form 8-K - Current report
11/29/2023	08:15	GLOBE	Panbela Announces 2nd Independent Safety Review of the..
11/24/2023	16:30	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/22/2023	17:01	EDGAR2	Form S-1 - General form for registration of securities under..
11/09/2023	16:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:10	EDGAR2	Form 8-K - Current report
11/09/2023	16:10	GLOBE	Panbela Provides Business Update and Reports Q3 2023..
11/03/2023	17:25	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
11/03/2023	17:24	EDGAR2	Form 8-K - Current report
11/03/2023	07:55	GLOBE	Panbela Therapeutics Announces Exercise of Warrants and..
11/02/2023	08:15	GLOBE	Panbela Announces Publication of Preclinical and Clinical..
10/31/2023	08:15	GLOBE	Panbela Announces Validation of European Patent in UK,..
10/25/2023	08:15	GLOBE	Acceptance of Polyamine Inhibitor CAR-T Combination Abstract..
10/24/2023	08:15	GLOBE	Panbela to Host Third Quarter 2023 Earnings Conference Call..